US/UK/Canada

Share

About Us

Mertiva AB (former Diamyd Medical) primarily consists of holdings in liquid assets and holdings in Protein Sciences Corporation and Mercodia AB. Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small Cap) in Stockholm (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY) administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).

Pick a time period -
Tags ( Active)

Bulletin from Extraordinary General Meeting of Diamyd Medical AB

At today’s Extraordinary General Meeting of Diamyd Medical AB, a resolution was passed to approve the proposed restructuring of the Diamyd Group. The General Meeting approved the following resolutions: Change of name to Mertiva ABDiamyd Medical AB will be renamed Mertiva AB. The subsidiary Diamyd Therapeutics AB will assume the name Diamyd Medical AB. Distribution of subsidiaryThe shares in the subsidiary Diamyd Therapeutics AB (future Diamyd Medical AB) will be distributed to the shareholders. The subsidiary will own the Group’s diabetes operations and the holding in Periphagen

Information relating to the Extraordinary General Meeting of Diamyd Medical on April 22 regarding the proposed restructuring of the Diamyd Group

Provided that the Extraordinary General Meeting of Diamyd Medical AB to be held on April 22 resolves in favor of the proposed restructuring of the Diamyd Group, after which Diamyd Medical AB will be renamed Mertiva AB, the incoming Board of Directors in the future Mertiva AB plans to appoint Andreas Bergsten as the President at a statutory meeting following the General Meeting. The proposed restructuring entails, among other effects, that the subsidiary Diamyd Therapeutics AB will be distributed to shareholders and the intention is to list the company on NASDAQ OMX First North. The current

Information about Summons to Extraordinary General Meeting of Diamyd Medical AB

The following summons to an Extraordinary General Meeting of Diamyd Medical AB will be available at Diamyd Medical’s website www.diamyd.com from Monday March 25, 2013. Summons to Extraordinary General Meeting of Diamyd Medical ABThe shareholders of Diamyd Medical AB (publ) are hereby summoned to an Extraordinary General Meeting at 2:00 p.m. on Monday, April 22, 2013, at Garnisonen Konferens, Karlavägen 100 in Stockholm, Sweden. AttendanceShareholders who wish to attend the Meeting must be recorded in the register of shareholders held by Euroclear Sweden AB by Tuesday April 16,

Extraordinary General Meeting to address the proposal by a group of shareholders that Diamyd Medical enter into immediate liquidation

On February 8, 2013, a group of shareholders submitted a request in writing to the Board of Directors of Diamyd Medical that the Board convene an extraordinary General Meeting to address their proposal that Diamyd Medical enter into immediate liquidation. The shareholders claimed to represent 8,883,351 Series B shares in Diamyd, corresponding to about 21 percent of the votes and 30 percent of the total number of shares. In addition to the proposed liquidation, the group of shareholders proposes that the General Meeting elect a new Board of Directors, that the company change its name to

Information about Summons to Extraordinary General Meeting of Diamyd Medical AB

The following summons to an Extraordinary General Meeting will be available at Diamyd Medical's website www.diamyd.com from Friday, December 21, 2012.Summons to Extraordinary General Meeting of Diamyd Medical AB The shareholders of Diamyd Medical AB (publ) are hereby summoned to an Extraordinary General Meeting at 2:00 p.m. on Thursday, January 31, 2013, at Kungsträdgården, Garnisonen Konferens, Karlavägen 100 in Stockholm, Sweden. AttendanceShareholders who wish to attend the Meeting must be recorded in the register of shareholders held by Euroclear Sweden AB by Friday, January 25,

Summons to Extraordinary General Meeting of Diamyd Medical AB

The shareholders of Diamyd Medical AB (publ) are hereby summoned to an Extraordinary General Meeting on Tuesday October 30, 2012 at 3.00 p.m. in Hagaparken, Garnisonen Konferens, at Karlavägen 100 in Stockholm, Sweden.Attendance Shareholders who wish to attend the meeting must be recorded in the register of shareholders held by Euroclear Sweden AB by Wednesday October 24, 2012, and must also notify Diamyd Medical of their intention to attend the Meeting by mail to Diamyd Medical, Karlavägen 108, SE-115 26 Stockholm, by e-mail to investor.relations@diamyd.com or on the Company's website,

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media